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ABSTRACT 
In the present study, footshock, which produces a powerful aversive emotional 
response was used in a Pavlovian conditioning experiment as an unconditioned 
stimulis (UCS), and was paired with the presentation of a light used as a 
conditioned stimulis (CS). There is an accumulation of evidence that supports the 
assertion that dopaminergic (DA) neurons within the ventral tegmental area 
(VTA) are active in processes that contribute to the amygdala-based circuitry 
involved in regulating emotionally salient responses. To build upon findings 
implicating VTA DA, excitatory glutamate (Glu), NMDA and AMPA receptors, 
were examined with respect to their role in Pavlovian conditioned fear 
responding. Fear potentiated startle (FPS) was used to assess the effects of 
intra-VTA infused AP5, and intra–VTA infused CNQX on conditioned fear 
responding in laboratory rats. The administration of the NMDA receptor 
antagonist AP5 (at 1.0, 2.5, and 5.0ug doses), blocked the ability of a conditioned 
stimulus (CS) previously paired with footshock to become conditioned to the 
UCS.  Similarly, administration of the AMPA receptor antagonist CNQX (at 1.0, 
2.5, 5.0ug doses), inhibited the ability of the CS to become conditioned to the 
UCS. The results of this study indicate the VTA is an important site for synaptic 
modifications associated with fear learning, and that activation of excitatory 
Glutamatergic receptors in the VTA play a necessary part of the processing 
underlying fear conditioning. Measures of shock reactivity demonstrated that the 
infusion of AP5 and CNQX into the VTA did not inhibit baseline startle 
amplitudes. The administration of AP5 and CNQX did not suppress 
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the perception of footshock as an aversive stimulus. This study provides further 
definition to established knowledge surrounding the neural processes whereby 
neutral environmental cues gain negative emotional salience as occurs in fear 
conditioning. It was hypothesised that the action of excitatory glutamatergic 
transmission within the VTA acts on NMDA and AMPA receptors is to assist in 
the acquisition of Pavlovian conditioned fear, possibly through the same synaptic 
mechanisms that govern LTP.  
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1.0  INTRODUCTION 
 
 In the presence of an aversive stimulus the experience of fear and anxiety 
typically produces species typical responses promoted to avoid danger and 
promote an organism’s continued survival (Öhman & Mineka, 2001; Rosen & 
Schulkin, 1998). The emotional responses promoted by fear and anxiety are 
performed by that animal innately. A reflexive defence response elicited by a 
threatening stimulus is considered adaptive because it provides a response when 
required and then subsides once the threat is removed (Mowrer, 1947; Rosen & 
Schulkin, 1998). Adaptive fear and other emotional states in general are 
distinguished from pathological states of fear and anxiety. Pathological emotional 
responses to threat may often develop through normal adaptive fear and anxiety 
responses. They are also common features of many pathological disorders that 
display symptoms characterised by over anxiety and excessive fears. These 
include psychiatric disorders such as drug induced psychosis (Kokkinidis & 
Anisman, 1980), schizophrenia (Flack, Laird, & Cavallaro, 1999), and 
generalised anxiety disorder (Sullivan, Coplan, Kent, & Gorman, 1999) for 
instance. Pathological disorders such as these are typically so severe and 
chronic in nature that they impair an individual’s ability to function in an adaptive 
fashion. During adaptive fear states, brain activity is raised and then returns to 
pre-fear levels upon removal of the threatening stimulus. Conversely, 
pathological fear states and similar psychiatric disorders are characterised by 
overactive neural circuitry which works to sensitise an individual to perceiving 
external threats. As a result of this neural potentiation subsequent pathological 
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responses become more easily initiated (Rosen & Schulkin, 1998). As a 
consequence it is suggested that the over activation or sensitisation of fear 
circuits involved in adaptive fear responding become triggered independently and 
autonomously by stimuli misperceived as dangerous (Rosen & Schulkin, 1998).  
  
 It has been shown that human and animal emotional responses to 
aversive stimuli produces individual neurochemical physiological, behavioural, 
and autonomic changes (Blanchard, Yudko, Rodgers, & Blanchard, 1993). 
Alterations in fear associated physiological arousal include increased plasma 
corticosteroid release, bradycardia or tachycardia (Iwata & LeDoux, 1988), and 
altered blood pressure, respiration, startle, and alertness (Rosen & Schulkin, 
1998). It is important to define the mechanisms responsible for the role it plays in 
the production of defensive behaviours, including those that occur in developing 
psychiatric disorders. This is due to the costly psychosocial, psychological, and 
biological consequences that arise from emotional regulation (McEwen & 
Mendelson, 1993). Research has demonstrated the importance of the amygdala 
through its various roles within the neural functioning involved in mediating and 
modulating the neurochemical processes governing fear conditioning and fear 
motivated responding (Davis, 1992; 1997; Fendt & Fanselow, 1999; LeDoux, 
1992, 2000).  
  
 Research into processes underlying fear conditioning has benefited 
immeasurably from the utilisation of animal models of fear which have provided 
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the opportunity to both analyse the behavioural and neurochemical components 
involved in the fear state. This has been accomplished through the manipulation 
of certain environmental variables, and neurochemical functioning through drug 
administration, or the lesioning of areas within the brain that are involved in 
emotional processing. In order to develop a more comprehensive understanding 
of the complex neural interactions involved in conditioned fear and its 
consideration of its role, the amygdala in relation to the acquisition and 
expression of conditioned fear will be discussed. Within this framework 
established research involving the VTA and its role in fear conditioning will be 
highlighted and broadened to incorporate research into LTP and findings from 
this study implicating the excitatory amino acid (EAA) glutamate (Glu), and drugs 
that moderate the function of Glu’s receptors. The action of Glu NMDA and 
AMPA receptors will be discussed in relation to the processes involved in the 
synaptic strengthening underlying Pavolovian fear conditioning, known namely as 
long term potentiation (LTP). NMDA receptors have been shown to be involved in 
the neural processes within the amygdala and other brain areas governing LTP. 
The NMDA and AMPA receptor antagonists produced results that indicate an 
important role for VTA and the function of its neural circuitry. Discussion of 
results of this study will be discussed and implications that come from this 
experiment will be considered concluding this thesis.   
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1.1  The Fear Response 
  
 To ensure human and mammalian survival in general, the motivating state 
of fear promotes the automatic activation of defence systems composed of inputs 
from behavioural, cognitive, and physiological components of the central nervous 
system (Öhman & Mineka, 2001). Animal and humans both quickly learn to fear 
stimuli that have the potential to endanger their survival. Fear characteristically 
activates an animal’s escape and avoidance strategies which include freezing, 
escaping, and or defensively attacking (fight or flight) (Öhman & Mineka, 2001). 
Species typical defences such as these typically occur automatically, however 
human defence strategies do profit from more sophisticated pre-conscious and 
conscious processing. Contingencies that exist between certain environmental 
and physiological stimuli, can for example come to signal potential negative 
consequences. These consequences, innately anticipated by an organism serve 
to heighten fear and trigger those defensive responses innately designed to 
defend an organism and promote its survival. When fear is viewed in a purely 
functional way, its purpose then is motivated escape or avoidance (Öhman & 
Mineka, 2001).  
 
1.2 Fear Conditioning – Fear Potentiated Startle Response 
  
 Pavlovian conditioning employs aversive classical conditioning techniques 
which can be used to decipher neural mechanisms responsible for transforming 
non threatening external stimuli into conditioned stimuli (CS) with negative 
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emotional salience (LeDoux, 1993). Conditioned stimuli (CS) such as tones, 
lights, and contexts that have been paired with an aversive stimulus (UCS) such 
as footshock, then become able independent of the UCS to elicit an array of 
functional defensive responses (LeDoux, 1993). The CS acquires its aversive 
properties via repeated presentations with the UCS (LeDoux, 1993). Within this 
paradigm the fear potential startle response (FPS) is used as it provides a natural 
measurement of fear. Once rats are conditioned to several pairings of light (CS) 
and footshock, the mean amplitude of the rats’ startle response to an 
unconditioned stimulus (US) such as a noise or tone typically between 100% 
greater when the noise is presented together with the light (CS) (Fendt & 
Fanselow, 1999).  
  
 The measure of fear represented by this paradigm is the fear potentiated 
startle response (FPS). This is derived by taking the difference between the light 
plus noise and the noise alone trials (Fendt & Fanselow, 1999). The FPS 
response displays sensitivity to chemicals that have been shown to mediate, 
moderate, or inactivate an animal’s response to fear eliciting stimuli (Fendt & 
Fanselow, 1999). This allows investigation into the neural mechanisms that are 
involved in processing fear. The FPS response is operationally defined by an 
increase in startle amplitude upon presentations of a cue previously paired with 
shock (Davis, 1986). The value of fear potentiated startle as a measure of fear 
lies in its replicability and reliability in both human and animal subjects. Since the 
startle response is instinctive rather than a learned response, its ability to provide 
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a behavioural indicator (Falls & Davis, 1995; Hitchcock & Davis, 1991; Kim & 
Davis, 1993). Benefits of using the startle response as a measure of fear include 
its ability to provide a behavioural indicator that can be manipulated 
experimentally (Koch, 1999). Subjects develop fear responses that can be 
conditioned to various stimuli including the context or setting where the CS and 
the US are presented. This is due to the ease with which conditioned stimuli can 
become feared after only a few brief presentations (Koch, 1999).  
 
 Stimuli conditioned to be feared evoke in animals a number of innate 
defensive mechanisms considered to reflect the state of pavlovian conditioned 
fear. These include the behavioural acoustic startle reflex (ASR), and the fear 
potentiated startle response (FPS) (Fendt & Fanselow, 1999). Experimental 
manipulation of the neurocircuitry that mediates learned fear can be made to test 
whether specific brain structures and specific neural processes are involved in 
fear conditioning during experimental testing (Fendt & Fanselow, 1999). During 
fear conditioning when a certain structure within the brain is lesioned, the point in 
the experiment when this lesion was administered determines what the data can 
comment on. For example, data gathered from testing where drug administration 
was given prior to the pre-training stage of conditioning, would relate to the target 
structures function in the acquisition stage of fear conditioning (Fendt & 
Fanselow, 1999). On the other hand, results that come from a post-conditioning 
lesion will provide information of that structure’s involvement in the expression of 
conditioned fear (Fendt & Fanselow, 1999). 
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 It can be inferred that the FPS response provides a survival or protective 
function for animals and humans. For instance, rats have been observed to 
display an attenuated acoustic startle response when presented with an aversive 
stimulus (Greba et al., 2000). Research has shown that when rats are presented 
with a cue that consistently predicts an aversive event, the CS attenuates the 
startle response (Davis, 1989). The FPS response also displays high sensitivity 
to drugs involved in the neural processing responsible for fear production (Fendt 
& Fanselow, 1999). Drugs such as norepinephrine antagonists, dopamine 
antagonists, opiod antagonists, NMDA associated glycine receptor antagonists, 
and NMDA antagonists have been shown to block or reduce the FPS response 
following administration. The anxiolytic effects of these drugs have also been 
shown to apply in human studies (Fendt & Fanselow, 1999; Davis, 1986; 1993). 
To date a number of independent studies into the basic processes underlying 
FPS have developed a picture which suggests that the enhancement of startle 
within the Pavlovian conditioned fear paradigm involves the amygdaloid complex 
(Fendt & Fanselow, 1999). 
 
1.3 The Amygdala and Fear Potentiated Startle Response 
  
 Electrical stimulation of the amygdala has been shown to increase the 
amplitude of the startle response (Rosen & Davis, 1988). To confirm the 
amygdala’s role in the activation of the FPS response, Koch and colleagues 
administered injections of glutamate into the central nucleus of the amygdala. 
This  produced a strong short latency potentiation of the FPS response, whereas 
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a long latency increase in the FPS response was produced following selective 
metobotropic glutamate receptor agonist administration to the amygdala (Koch & 
Ebert, 1993). Experimental research has shown that the basolateral amygdala 
plays a key role in fear learning, whereas the central nucleus plays a more 
predominant role than the basolateral amygdala in conditioned fear expression 
(Campeau, Miserendino, Davis, 1992; Fendt & Fanselow, 1999). 
  
 Research that first investigated the amygdala’s role in the production of 
FPS was carried out by Davis and colleagues nearly thirty years ago. Davis 
showed that the neural circuitry connecting the amygdala and PnC is a 
necessary link in the conditioned fear potentiating startle response (Fendt & 
Fanselow, 1999). It was initially shown that the startle response is potentiated 
upon caudal pontine reticular nucleus (PnC) activation (Fendt & Fanselow, 
1999). Amygdala lesion experiments consistently block FPS using a visual (CS) 
or an auditory CS (Hitchcock & Davis, 1986; Hitchcock & Davis, 1987). Similarly, 
inactivation of the ventral amygdalofugal pathway which runs directly via the 
central nucleus of the amygdala to the PnC, blocks the FPS response (Fendt & 
Fanselow, 1999). The amygdala’s role in emotion is not limited to processing 
conditioned associations, electrolytic lesions of the rat amygdala demonstrated 
the entire removal of innate defensive and survival behaviours that are expected 
to be displayed upon presentation of a natural predator, (i.e. a cat) (Rosen et al., 
1998). Electrical stimulation of the amygdala on the other hand has been shown 
to produce species typical behaviours associated with the fear state, including 
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acoustic startle (Rosen & Davis, 1988), bradycardia (Kapp, Gallagher, 
Underwood, McNall. & Whitehorn, 1982), corticosterone release (Dunn & 
Whitener, 1986), and elevated heart rate (Kapp et al., 1982). The amydaloid 
complex in general is involved in the neural process that underlie the acquisition 
and expression of conditioned fear. 
  
 It has been established that the amygdala is particularly sensitive to 
stimuli paired with shock (Fendt & Fanselow, 1999). The amygdala lies within the 
temporal lobes of the brain and consists of five major subdivisions containing a 
complex array of interconnected nuclei (Amaral, Price, Pitkanen, & Carmichael, 
1992). The amygdala’s involvement includes contributing to many of the 
neuromodulatory components that are involved in fear responding (ie. freezing, 
heart rate changes, hypoalgesia, and potentiated startle (Rosen & Schulkin, 
1998). The amygdala receives inputs from sensory stimuli that induce fear, and it 
also provides a pathway that is involved in activating certain aspects of fear 
related behaviours required for the organism to respond to and recover from a 
threat (Rosen et al., 1998). Of the major divisions, the basolateral amygdaloid 
nuclei and the central amygdaloid nuclei have received most attention.  
 
 Lesions of the central, lateral, and basolateral amygdala produce 
disruption in the expression of physiological fear related behaviours such as fear 
induced bradycardia, respiratory changes, startle and freezing (Rosen et al., 
1998). Conversely, electrical stimulation of the central nucleus of the amygdala 
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induces bradycardia, freezing, and increases in acoustic startle responding 
(Rosen et al., 1998). Both the lateral and the basolateral nuclei of the amygdala 
receive innervations from an array of sensory, auditory, and nociceptive sources 
(Rosen et al., 1998). There is evidence that the basolateral and lateral nucleus 
play a significant role in storing aversive measures (Rosen et al., 1998). For 
example, cells within the lateral nucleus of the amygdala respond to stimuli 
conditioned to be feared (Rosen et al., 1998). Lateral and basolateral nuclei 
contain a large concentration of large pyramidal cells which are similar to cortical 
cells whose role is to integrate incoming information throughout the cortex 
(Rosen et al., 1998).  It has been shown that administration of N-methyl-D-
asparate (NMDA) antagonists, which have been shown to block forms of learning 
when administered into the amygdala, block fear conditioning (Rosen et al., 
1998). Administration of DL-2-amino-5-phosphonopentanoic acid (AP5), a 
glutamatergic NMDA receptor antagonist into the basolateral nucleus of the 
amygdala blocked the acquisition of fear. This indicates that the processes that 
occur during fear conditioning are mediated in some way by NMDA receptors 
within the amygdala. 
  
1.4 Amygdala and Fear Expression 
 
 Research that has involved lesions and drug infusions of the amygdala 
has shown it to be an important mediating structure involved in the acquisition 
and expression of conditioned emotional behaviour and defensive responding 
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(Fendt & Fanselow, 1999; Davis, 1992). The amygdala has been demonstrated 
to be an essential structure involved in the acquisition of fear potentiated startle. 
Davis and colleagues (1992) administered the NMDA receptor antagonists AP5, 
AP7 and pertussin toxic directly into the basolateral nucleus of the amygdala. All 
three of the drugs administered subsequently blocked the acquisition of fear 
potentiated startle. This is consistent with the assertion that NMDA receptors in 
the basolateral nucleus of the amygdala play a role in the neural circuitry  
associated with the induction of fear conditioning (Fendt & Fanselow, 1999). 
  
 It has been shown that lesions administered directly into the amygdala 
prior to fear conditioning blocked the FPS response (Hitchcock & Davis, 1986). In 
addition, electrolytic lesions administered to the amygdala post fear conditioning 
have also been shown to block the FPS response. This indicates that the 
amygdala’s role is not limited to activation by fear eliciting stimuli, but is also 
involved in mediating conditioned fear expression over time (Kim & Davis, 1993).  
  
 Consistent with this assertion are results arising from studies employing 
excitotoxin and electrolytic lesions of the central nucleus of the amygdala in the 
fear potentiated startle paradigm (Campeau & Davis, 1995; Falls & Davis, 1995; 
Hitchcock & Davis, 1986, 1987). Electrolytic lesions of the central nucleus were 
shown to enhance fear motivated behaviour after lesioning to other brain areas 
that have been shown to mediate the inhibition of fear responding (Melia, 
Sananes & Davis, 1991). For example, the observed increase in fear potentiated 
   13
   
startle which has been demonstrated post-lesioning of the septal region of the rat 
brain, is blocked when the central nucleus of the amygdala is subsequently 
impaired (Melia et al., 1991). It has been suggested that the predominant role of 
the amygdala in responding to aversive emotional events is in the formation, 
initiation, and expression of conditioned pavlovian fear responses. Although the 
amygdala seems to play a large role in functions contributing to FPS, other 
limbic, and subcortical regions of the mammalian brain are thought to initiate 
other mediating and or modulating mechanisms within the fear system around 
which the amygdala is based.  
 
 Circuitry extends from within the central nucleus of the amygdala to the 
elemental startle pathway. This pathway works to mediate fear potentiated startle 
expression (Fendt et al., 1999). Kim, Campeau, Falls and Davies (1993) found 
that injections of CNQX, an AMPA receptor antagonist, into the central or 
basolateral nucleus of the amygdala, successfully blocked the expression of fear 
potentiated startle. In summary, although the central nucleus does not play a role 
in the acquisition of conditioned fear, the role it has in the expression of fear has 
been established (Fanselow & Kim, 1994). 
1.5 The Ventral Tegmental Area Neuroanatomical and Neurochemical 
 Connectivity 
  
 The VTA has been defined as a few groups of heterogeneous cells 
positioned on the midline on the base of the mesencephalon, dorsal to the 
substantia nigra, however very few clear physical boundaries differentiate the two 
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structures (Oades & Halliday, 1987). Both areas display similar cellular structure 
and particularly pathways with innervations. For this reason, dissociation of one 
area from the other is benefited by functional over structural change. Forebrain 
projections of DA containing neurons within the A10 cell grouping of the Ventral 
Tegmental Area (VTA) are part of the mesocorticolimbic system. This region is 
known as the Ventral Tegmental Area (VTA). There is evidence accumulating 
that infers the VTA plays a prominent role in governing response to reward 
(Blackburn, Pfaus, & Phillips, 1992; Dahlstrom & Fuxe, 1964; Oades & Halliday, 
1987; Salamone 1994; Swanson, 1982; Greba, Munro, & Kokkinidis, 2000). 
Additional evidence points to the role of the mesoamygdaloid pathway within this 
system and that it contributes to conditional fear processing (Greba et al., 2000). 
Swanson (1982) reported that of the approximately 27,000 cells which make up 
the VTA, it was estimated that up to 70% were dopaminergic. Deutch (1985) and 
colleagues have demonstrated that activation of VTA DA neurons increases the 
metabolism of DA within both the central and basolateral nuclei of the amygdala 
(Coco, Kuhn, Ely, & Kilts, 1992; Deutch, Tam, & Roth, 1985). The two 
amygdaloid nuclei have shown themselves to be essential in the processing and 
performance of responses to conditioned fear stimuli (Davis, 1992; Munro & 
Kokkinidis, 1997). It is suggested from these studies that VTA DAergic 
transmission within the VTA is involved in the fear circuitry within the 
mesocorticolimbic system.  
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1.6 Long Term Potentiation 
  
 Long term potentiation was first described by Bliss and Lomo (1973) over 
thirty years ago. They postulated that neurocircuitry governing learning and 
memory was mediated by excitatory synaptic changes (Bliss et al., 1973). The 
hypothesis asserts that long-lasting alterations in synaptic strength occur during 
learning that enables new associations to be made and stored in memory for 
later use (Martin, Grimwood, & Morris, 2000). LTP has been demonstrated in the 
hippocampal formation in many experiments (Stanton & Senowswki, 1989; 
Christofi, Nowicky, Bolsover, & Bindman, 1993). Since it can be produced in 
slices of the hippocampal formation held in isolation and also in living animals, 
LTP provides researchers a model of learning that can be manipulated in order to 
analyse the effects of biochemical alterations on memory formation (Holscher, 
1997).  
 
1.7 Excitatory Glutamate Receptors 
  
 LTP is mediated by two cellular processes at the synaptic level. It has 
been shown that both of these involve the action of the excitatory 
neurotransmitter glutamate, and the ionotrophic glutamate receptors NMDA and 
AMPA. When glutamate binds with AMPA receptors, an excitatory post-synaptic 
potential (EPSP) is produced (Huettner et al., 2003). NMDA receptors contribute 
to synaptic strengthening through the action of calcium dependent ion channels. 
Glutamate stimulation of NMDA receptors and post synaptic depolarisation are 
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both required to initiate LTP. NMDA receptors remain blocked until the post 
synaptic membrane where the receptor is located is depolarised which promotes 
the release of Magnesium ions lying within the receptors structure. The action 
NMDA receptor activation and the depolarisation of the post synaptic membrane 
promote the entry of Calcium ions which promote a number of intra-cellular 
processes involved in LTP. 
 
1.8 Ventral Tegmental Area Dopamine and Fear Conditioning 
 
 The role of dopamine in the production of conditioned fear has been 
postulated to involve a number of mesocorticolimbic DA projections that originate 
in the VTA. Areas within the forebrain that receive VTA DA connections include 
the amygdala, hypothalamus, hippocampus, and the medial prefrontal cortex. 
The basolateral amygdala receives VTA DA innervations that have been 
suggested to mediate emotional learning and memory recall (Greba, Giftkins, & 
Kokkinidis, 2001; Greba & Kokkinidis 2002; Nader, Schafe, & LeDoux, 2000). DA 
projections from the VTA have been shown to be involved in motivational 
behaviour linked to drug, appetite and reproductive reinforcement (Borowski & 
Kokkinidis, 1996). The VTA comprises an important position within the 
neuroanatomical system that research suggests plays an essential role in natural 
reinforcement and the conditional effects of drug abuse (Bonci & Malenka, 1999).  
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  It has been suggested that DA neurons within the VTA may play a role in 
various processes involved in aversive emotional experiences. It has been 
shown for example that mild stress exposure to cues conditioned to be feared 
increases early gene expression and enhances the metabolism of VTA DA (Beck 
& Fibiger, 1995; Borowski & Kokkinidis, 1996; Deutch, Tam, & Roth, 1985). 
Deutch and colleagues (1991) demonstrated increases in VTA c-fos elicited by 
conditioned fear cues. Electrical stimulation of the VTA in cats provokes 
characteristic fear like behaviours (Stevens & Livermore, 1978). Conversely, VTA 
lesions in rats produces hypoemotivity (Le Moal, Stinus, & Cardo, 1969). 
Research that adds further weight to VTA DA’s role in conditioned fear 
expression comes from studies examining the stimulation of the PPTg. Electrical 
stimulation of PPTg neurons increases DA neural activity within the VTA 
(Kelland, Freeman, Rubin, Chiodo, 1993; Greba et al., 2000). This is consistent 
with results found suggesting that PPTg excitation through fear evoking stimuli 
contributes to emotional disturbances within the amygdaloid complex, and further 
supports research demonstrating the VTA’s role in amygdala mediated DA 
dependent fear responding (Greba et al., 2000).  
 
  
 Two sources of neurotransmission that regulate DA neural excitation 
within the ventral mesencephalon include Acetylcholine (ACh) and gamma-
amino-butyric-acid (GABA). The release of Ach within the VTA produces an 
excitatory effect on DA activity (Blaha, Allen, Das, Inlis, Latimer, Vincet, & Winn, 
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1996; Hallanger & Wainer, 1988; Jackson & Crossman, 1983; Oakman, Faris, 
Kerr, Cozzari, & Hartman, 1995; Woolf, 1991). GABA containing neurons found 
in the VTA are known to synapse on DA cells and inhibit GABA neural activity 
(Giftkins, Greba, & Kokkinidis, 2002). It has been shown that fear motivated 
responding and patterns of DA neural firing are mediated by inhibitory GABA 
interneurons. The release of Ach within the VTA produces an excitatory function, 
increasing VTA DA neural activity (Greba et al., 2000). Research has shown that 
application of Ach, muscarine and carbachol produces increases in DA cell firing. 
The increase in cell firing, or depolarisation produced by Ach administration is 
blocked by methylscopolomine, a non-specific muscarinic receptor antagonist 
(Lacey, Calabresi, North, 1990; Westerink, Kwint, De Vries, 1996; Greba et al., 
2000). 
  
 A further role for VTA DA arises from its mesolimbic projections to the 
basolateral and central nuclei within the amygdala (Borowski & Kokkinidis, 1996). 
Electrical stimulation of the VTA has been shown to potentiate amygdala kindling 
which contributes to alterations in VTA neural firing (Maeda & Mogenson, 1981). 
Animal experiments using both chemical and electrical lesions have 
demonstrated that the effective interference on VTA DA contributes to a 
disruption in classically conditioned fear (Borowski & Kokkinidis, 1996; Munro & 
Kokkinidis, 1997). It has also been shown that neurotoxic lesions made within the 
VTA removes the ability of an externally explicit CS to attenuate the 
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measurement of the acoustic startle response (Borowski & Kokkinidis, 1996; 
Davis, 1992; Greba, Munro, & Kokkinidis, 2000).  
  
 In addition to DA involvement within the VTA, DA efferents that arise 
through VTA neurons are projected to the amygdala via the mesocorticolimbic 
pathway (Greba et al., 2000; Munro et al., 1987; Oades & Halliday, 1987; 
Swanson, 1982). It has been shown that 6-OHDA lesions of the VTA results in a 
consistent loss of up to 90% of amygdaloid DA (Oades et al., 1987). The 
importance of the mesoamygdaloid DA pathway is further strengthened by 
studies examining the prefrontal cortex and its role in fear responding. For 
instance, an increase in DA is displayed in both the VTA and the PFC after 
exposure to a mild stressor (Deutch et al., 1965; Borowski et al., 1996). The 
action of DA within the PFC is reduced when the central amygdala is lesioned 
(Borowski et al., 1996), and concentrations within the VTA are lowered as a 
consequence of lesioning. Within the VTA two major cell types predominate 
Dopaminergic, and GABAergic. DA neurons are noted to play the primary role, 
releasing DA via efferents to areas including the nucleus acumbens, amygdala, 
and prefrontal cortex (Bonci et al., 1999; Swanson, 1982; Munro et al., 1997). It 
has been shown that the majority of non-DA cells within the VTA are GABAergic 
and their role is to inhibit the potential of VTA DA neurons (Bonci et al., 1999; 
Kalivas, 1993; White, Hu, & Henry, 1993). Inputs via from the prefrontal cortex 
make excitatory synaptic connections onto VTA DA and GABA cells (Bonci et al., 
1999; Kalivas, 1993; White et al., 1993) which contain NMDA and non-NMDA 
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Glu receptors. These glutamatergic receptors work to facilitate synaptic action 
and also long term potentiation (Bonci et al., 1999). 
 
 The GABAA agonist muscimol, when infused into the VTA suppresses DA 
neural activity. Muscimol also works to block the expression of FPS when 
administered to the VTA (Munro & Kokkinidis, 1997). It has been suggested that 
GABA receptors in the VTA may play a role in the anti-anxiety effects of 
benzodiazepine drugs which facilitate inhibition by facilitate GABA and chloride 
channels at the GABAA complex (Richards & Mohler, 1984). Cholinergic 
projections from neurons that arise from within the Pedunculopontine Tegmental 
Nucleus (PPTg) and the Laterodorsal Tegmental Nucleus (LDTg) both innervate 
the VTA (Blaha et al., 1996; Greba, Munro, & Kokkinidis, 2000). Interestingly, 
PPTg neurons provide one possible source for EAA projections to the VTA. This 
raised the possibility that another neurotransmitter, glutamate, may be involved in 
the synaptic neural plasticity associated with aversive emotional function of fear 
conditioning. It has been demonstrated that VTA DA neuronal activity increases 
upon administration of both glutamate and NMDA to midbrain VTA slices (Wang 
& French, 1993). NMDA administrated directly into the VTA produces an 
increase in locomotor activity (Kalivas, Duffy, Barrow, 1989; Pycock & Dawbarn, 
1980; Willick & Kokkinidis, 1995). Conversely, in vivo electrophysiological 
experiments have demonstrated that DA and DA agonist drug administration to 
the VTA produces a reduction in DA neuronal firing rates (White & Wang, 1984). 
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 It has been demonstrated that mesolimbic DA neurons are regulated by 
somatodendritic DA D2 receptors (White et al., 1997). Administration of the DA 
D2/3 agonist quinpirole to in vitro VTA slice preparation inhibits VTA DA neurons 
(Munro & Kokkinidis, 1997). It does this through its actions on DA autoreceptors, 
therefore a decrease in VTA DA is most likely the reason for quinpirole’s 
suppression of fear potentiated startle (Borowski & Kokkinidis, 1996).  
2.0  MATERIAL and METHOD 
 
2.1 Subjects 
 
Fifty six naïve male albino rats of the Wistar strain were used for the 
experiments. The rats weighed approximately between 300-350g at the 
beginning of the experiments.  The rats were bred in the University of 
Canterbury’s Psychology laboratory and were held in a climatically controlled 
colony environment, in grouped-housing with free access to food and water. 
Animals were maintained on a 12 hour light and dark cycle (lights on at 8am) and 
behavioural testing was conducted during the light cycle. 
 
2.2 Apparatus 
  
 The acoustic startle reflex amplitudes and footshock delivery was 
measured in four identical cages (16.5 cm x 8 cm x 9 cm) located inside sound 
attenuating melamine chambers (60 cm x 34 cm x 56 cm). The sides and lid of 
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each startle cage (Med Associates, Fairfield, VT) were manufactured from 
stainless steel horizontal rods 0.25 cm in diameter and were situated 1.5 cm 
apart. The floor of the startle cage also consisted of stainless steel rods but with 
a 0.45 cm diameter. A metal frame 10 cm away from each cage housed a 6.0 cm 
speaker. The startle cages were mounted on a Med Associates load cell-based 
startle platform (25 cm x 11.5 cm x 4.5 cm). Movement amplitude was rectified, 
digitised, and recorded by Med Associates software which controlled the white 
noise and scrambled shock stimuli. The acoustic stimulus produced by a 
programmable audio generator consisted of a 100-ms white noise burst with a 
rise-decay time of 10 ms.  Ambient noise level in each chamber was 36 dB as 
measured by a Bruel & Kjaer (Model 2235; Denmark) sound level meter (A 
Scale). The 600-µA footshock was delivered through the floor grid by constant 
current stimulators connected to commutators located on top of each sound 
attenuating chamber with stimulation leads attached to each startle cage. 
 
2.3 Procedure 
2.3.1 Surgery 
  
 Surgery was performed in accordance to the animal protocols that was 
approved by the Animal Ethics Committee at the University of Canterbury. 
Subjects first received Atropine Sulphate (0.12 mg/kg) prior to anaesthetic in 
order to dry-up mucous secretions. Twenty minutes later they were 
anaesthetised with Sodium Pentobarbitone (90 mg/kg) and put in a Stoelting 
Stereotaxic instrument (WoodDale, IL). Subjects also received a Mepivacaine 
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(local anaesthetic) scalp injection (20 mg/ml) before surgery and Ketofen, an 
anti-inflammatory (10 mg/ml) local injection prior to suturing as required by the 
ethical guidelines. The horizontal plane of the subject’s skull was levelled using 
the landmarks Bregma (anterior) and Lambda (posterior). Stereotaxic co-
ordinates were then calculated by using the stereotaxic atlas of the rat brain by 
Paxinos and Watson (1986; 1998). Stainless Steel guide cannulas (C313G, 
Plastics One, Roanoke, VA) were implanted bilaterally with an outer diameter of 
0.71mm. The co-ordinates for bilateral implants were at a 10° angle aimed 
1.0mm above the medial VTA, AP - 4.8mm, ML ± 2.4mm and DV – 7.5mm. The 
implants were then fixed to the skull using dental cement and four stainless steel 
jeweller’s screws (Lomat, Quebec, Canada). Subjects were then left to recover 
for approximately seven days before commencement of testing. 
 
2.3.2 Baseline Acoustic Startle (Pre-drug) 
 
The procedure of the proposed experiment has been approved by the 
Animal Ethics Committee of the University of Canterbury. Seven days post-
surgery each subject’s acoustic startle threshold was measured. The rat was 
placed into the startle apparatus and given a 5-min period of acclimatisation. 
They then received two sessions of 30 white noise bursts with a fixed interval of 
20-s between each noise burst. The decibel level of the white noise bursts 
alternated between 91, 95 and 99 in intensity. Each subject were assigned to a 
particular decibel level according to their threshold. 
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2.3.3 Pavlovian Conditioning 
  
 The rats were put through a two day testing procedure consisting of 
Pavlovian conditioning and a fear test. Day one comprised of drug infusion prior 
to Pavlovian conditioning in which the subject was taken out of its holding cage 
and infused with either AP5, CNQX, or saline. The dummy cannulas were 
removed (C313DC, Plastics One) and 28-gauge (0.36) stainless steel infusion 
needles (C313I, Plastics One) were then inserted into each cannula. 
Polyethylene tubing (PE20, Plastics One) was pre-loaded with either AP5, CNQX 
or saline and attached to each cannula implant of the subject. The polyethylene 
tubing was attached to a 2µl Hamilton syringe and infused over a 1 minute period 
at a volume of 0.5 µl per side with infusion pumps (Model 310, Stoelting). After 
infusion stops, the needles were then left for a further 2 minutes, and then 
removed and replaced with the dummy cannulas. Pavlovian fear conditioning 
consisted of 20 pairings of light + shock which was presented to the subject in 
the startle chamber. The light (CS) was presented for a duration of 3.5-s, 
immediately followed by a 500-ms scrambled footshock (600µA) with an inter-
stimulus interval of 56-s. The second day consisted of a fear-potentiated startle 
test to measure the subject’s fear response.  The test involved 10 white-noise 
bursts set at the subject’s baseline startle level, with an inter-stimulus interval of 
30-s followed by 5 noise alone test trials and 5 noise + light trials, with an inter-
stimulus interval of 30-s. The light (CS) was presented for 3.5-s, followed 
immediately by a 100ms noise burst.  
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2.4 Perfusion and Histology 
  
 Fifty subjects with bi-cannula implants into the VTA were culled and then 
perfused intercardially with saline, followed by a 10% formalin solution. The 
brains were then removed quickly and stored in the formalin solution for one-day, 
and later transferred to a sucrose solution and refrigerated. The subjects’ brains 
were then sliced (50µm) after 2-3weeks storage using the cryostat and then 
mounted onto gel coated slides. The slides were then stained with cresyl violet 
and later evaluated using a microscope and the Stereotaxic atlas of the rat brain 
by Paxinos and Watson (1986; 1998) in order to verify the guide cannula 
placements.  
 
2.5 Statistical Analysis 
  
 The results of the expression of Pavlovian conditioned fear were analysed 
by a One-Way Analysis of Variance (ANOVA) in order to detect any significant 
differences in the acoustic startle levels between the experimental and control 
groups. To assess shock reactivity, movement scores were analysed by a One-
Way ANOVA. Movement scores were evaluated to observe if the drug had any 
effect on the animal’s ability to react to the shock and light in the Pavlovian 
Conditioning sessions.   
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3.0 RESULTS 
 
3.1 AP5 
 
Histology 
  
 Three rats in the AP5 5ug and 2.5ug were excluded from the study after 
developing loose acrylic headcaps. Guide cannula locations in the VTA for the 
remaining rats in each drug treatment group (AP5 5ug, N= 7, AP5 2.5ug, N=6, 
AP5 1.0ug, N= 8) are depicted in Figure 1. 
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Figure 1. A schematic representation of the guide cannula locations for the AP5 
5ug (N = 7), AP5 2.5ug (N = 6), and AP5 1.0ug (N = 8) infusion groups. Guide 
cannual placements were implanted at a 10° angle aimed 1mm above the VTA 
(co-ordinates AP - 4.8mm from bregma, ML ± 2.4mm from the sagital suture, DV- 
7.5mm from the skull surface). The representative sections (- 4.52mm, - 4.80mm, 
- 5.20mm, and - .30mm from bregma) were taken from The Rat Brain in 
Stereotaxic Coordinates, by Paxinos and Watson, 1986 and 1998.    
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3.2 Acoustic Startle and Selected Decibel Levels 
  
 The acoustic startle levels of the individual animals did not differ 
significantly across the Saline and AP5 groups during the baseline screening 
session, F (3,25) = 0.34, p = 0.80. Therefore, any difference seen in the startle 
levels of the animals post pavlovian conditioning were not as a result of variable 
baseline levels. The decibel levels selected for each subject also did not differ 
significantly between the Saline and AP5 groups, F = (3,25) = 0.45, p = 0.72. The 
noise burst decibel level varied between 91 – 99 dB, with an average of 94.59.   
 
3.3 Effect of AP5 Drug Infusion into the VTA on the Expression of 
 Pavlovian Conditioned Fear  
  
 In this experiment the Pavlovian conditioning sessions of 20 light + 
footshock pairings was accompanied 24 hours later by a fear potentiated startle 
test. The behavioural data are shown in Figure 2. Subjects that received 
intracranial infusions of saline served as a control group (N=8) for the animals 
that received intracranial infusions of AP5 prior to Pavlovian Conditioning 
sessions. A one-way ANOVA of the difference scores (light + noise – noise alone 
startle scores) was carried out between the AP5 (experimental) and saline 
(control) groups. ANOVA of the difference scores revealed a significant main 
effect for drug treatment, F(1,13) = 22.41, p<0.0004 (AP5 5ug vs. Saline),  
F(1,12) = 6.66, p<0.024 (AP5 2.5ug vs. Saline), and F(1,14) = 11.97, p<0.004 
(AP5 1.0ug vs. Saline) represented in Figure 3. The results reveal that infusions 
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of AP5 5ug, 2.5ug and 1.0ug into the VTA significantly decreases the startle 
amplitudes of the animals in response to the light + noise presentations. Post-hoc 
analysis using the Bonferroni test confirmed that the three varying doses of AP5 
used in the current study significantly decreased the fear potentiated startle 
response relative to the saline-treated control group. Therefore, the subjects in 
the three varying drug groups failed to demonstrate Pavlovian fear conditioning 
after receiving intra-VTA drug infusions of AP5 followed by 20 light + footshock 
pairings in comparison to the control group.   
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Figure 2. ANOVA results for subjects infused with saline (N = 8) or AP5 5ug (N = 
7), AP5 2.5ug (N = 6), and AP5 1.0ug (N = 8) into the VTA. Animals were 
Pavlovian Fear Conditioned and tested for fear-potentiated startle 24h following 
20 sessions of light + footshock. The AP5 drug groups significantly failed to show 
a light-associated increase of acoustic startle compared to the saline group (* 
p<0.0004, p<0.02, p<0.004).      
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Figure 3. Mean difference scores (light + noise – noise alone) following infusion 
of saline (N = 8) or AP5 5ug (N = 7), AP5 2.5ug (N = 6), and AP5 1.0ug (N = 8) 
into the VTA. 
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3.4 Shock Reactivity 
  
 In order to demonstrate that drug infusions did not significantly attenuate 
the shock reactivity of the subjects a one-way ANOVA was used. There was no 
significant difference in shock reactivity between the AP5 drug group and the 
saline group,  
F(2,26) = 1.47, p<0.25, ns. Therefore, the anxiolytic actions of AP5 infused into 
the VTA cannot be effected by possible drug effects on sensorimotor responding 
as a suppression of movement amplitude was not induced by the AP5 infusion 
(see Figure 4).  
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Figure 4. Mean movement amplitude recorded 100ms before shock and 100ms 
after shock onset following infusion of saline (N = 8) or AP5 5ug (N = 7), AP5 
2.5ug (N = 6), and AP5 1.0ug (N = 8) into the VTA. ANOVA did not reveal any 
significant difference between the groups. 
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4.0 RESULTS 
 
4.1 CNQX 
 
Histology 
 Three rats in the CNQX 2.5ug and 1.0ug were excluded from the study 
after developing loose acrylic headcaps. Guide cannula locations in the VTA for 
the remaining rats in each drug treatment group (CNQX 5ug, N= 8, CNQX 2.5ug, 
N=6, CNQX 1.0ug, N= 7) are depicted in Figure 5. 
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Figure 5. A schematic representation of the guide cannula locations for the CNQX 5ug 
(N = 8), CNQX 2.5ug (N = 6), and CNQX 1.0ug (N = 7) infusion groups. Guide cannual 
placements were implanted at a 10° angle aimed 1mm above the VTA (co-ordinates AP 
- 4.8mm from bregma, ML ± 2.4mm from the sagital suture, DV- 7.5mm from the skull 
surface). The representative sections (- 4.80mm, - 5.20mm, - 5.30mm, - 5.60mm, and - 
5.80mm from bregma) were taken from The Rat Brain in Stereotaxic Coordinates, by 
Paxinos and Watson, 1986, 1989    
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4.2 Acoustic Startle and Selected Decibel Levels 
  
 The acoustic startle levels of the individual animals did not differ 
significantly across the Saline and CNQX groups during the baseline screening 
session, F (3,25) = 0.66, p = 0.59. Therefore, any difference seen in the startle 
levels of the animals post pavlovian conditioning were not as a result of variable 
baseline levels. The decibel levels selected for each subject also did not differ 
significantly between the Saline and CNQX groups, F = (3,25) = 0.61, p = 0.61. 
The noise burst decibel level varied between 91 – 99 dB, with an average of 
94.72.   
 
4.3 Effect of CNXQ Drug Infusion into the VTA on the Expression of 
 Pavlovian Conditioned Fear  
  
 In this experiment the Pavlovian conditioning sessions of 20 light + 
footshock pairings was accompanied 24 hours later by a fear potentiated startle 
test. The behavioural data are shown in Figure 6. Subjects that received 
intracranial infusions of saline served as a control group (N=8) for the animals 
that received intracranial infusions of CNQX prior to Pavlovian Conditioning 
sessions. A one-way ANOVA of the difference scores (light + noise – noise alone 
startle scores) was carried out between the CNQX (experimental) and saline 
(control) groups. ANOVA of the difference scores revealed a significant main 
effect for drug treatment, F(1,14) = 13.1, p<0.003 (CNQX 5ug Vs. Saline), 
F(1,12) = 12.2, p<0.004 (CNQX 2.5ug Vs. Saline), and F(1,13) = 9.2, p<0.01 
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(CNQX 1.0ug Vs. Saline) represented in Figure 7. The results reveal that 
infusions of CNQX 5ug, 2.5ug and 1.0ug into the VTA significantly decrease the 
startle amplitudes of the animals in response to the light + noise presentations. 
Post-hoc analysis using the Bonferroni test confirmed that the three varying 
doses of CNQX used in the current study significantly decreased the fear 
potentiated startle response relative to the saline-treated control group. 
Therefore, the subjects in the three varying drug groups failed to demonstrate 
Pavlovian fear conditioning after receiving intra-VTA drug infusions of CNQX 
followed by 20 light + footshock pairings in comparison to the control group.  
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Figure 6. ANOVA results for subjects infused with saline (N = 8) or CNQX 5ug 
(N= 8), CNQX 2.5ug (N=6), CNQX 1.0ug (N= 7) into the VTA. Animals were 
Pavlovian Fear Conditioned and tested for fear-potentiated startle 24h following 
20 sessions of light + footshock. The CNQX drug groups significantly failed to 
show a light-associated increase of acoustic startle compared to the saline group 
(* p<0.003, p<0.004, p<0.01).      
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Figure 7. Mean difference scores (light + noise – noise alone) following infusion 
of saline (N = 8) or CNQX 5ug (N = 8), CNQX 2.5ug (N = 6), and CNQX 1.0ug (N 
= 7) into the VTA. 
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4.4 Shock Reactivity 
  
 In order to demonstrate that drug infusions did not significantly attenuate 
the shock reactivity of the subjects a one-way ANOVA was used. There was no 
significant difference in shock reactivity between the CNQX drug groups and the 
saline group, F(2,26) = 0.88, p<0.43, ns. Therefore, the anxiolytic actions of 
CNQX infused into the VTA cannot be effected by possible drug effects on 
sensorimotor responding as a suppression of movement amplitude was not 
induced by the AP5 infusion (see Figure 8).  
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Figure 8. Mean movement amplitude recorded 100ms before shock and 100ms 
after shock onset following infusion of saline (N = 8) or CNQX 5ug (N = 8), CNQX 
2.5ug (N = 6), and CNQX 1.0ug (N = 7) into the VTA. ANOVA did not reveal any 
significant difference between the groups. 
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5.0 GENERAL DISCUSSION 
 
5.1 Main Findings 
 
5.1.1 AP5 
  
 Intra-VTA infusion of 5ug, 2.5ug and 1.0ug of the NMDA receptor 
antagonist AP5 significantly blocked fear potentiated startle relative to the control 
group administered saline. The ANOVA supported the assertion that the saline 
administered control group displayed an increased fear potentiated startle 
response when compared to the drug groups administered 5ug, 2.5ug and 1.0ug 
of AP5 (Figures 2 & 3). Between groups ANOVA was carried out to determine 
whether there were any variations in shock reactivity post drug administration the 
results indicated that the three groups that received intra-VTA infusion of AP5 
displayed a reaction to shock comparable to the control group (Figure 4). This 
indicates that the drug did not impair the animal’s ability to experience the shock 
as aversive and respond appropriately. This data supports many assumptions 
made with regards to VTA DA neurons and their involvement within the 
neurocircuitry mediating fear conditioning (Greba, Munro, Kokkinidis, 2000). The 
results of the experiment also provide new insights into the role of the excitatory 
amino acid (EAA) Glutamate and its possible involvement in the neural 
processes modulating the changes that govern learning through synaptic 
plasticity.  
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 Aside from VTA containing neurons, the possibility exists that the infusion 
of the NMDA receptor antagonist AP5 exerted its affects upon neurons contained 
within neighbouring anatomical regions. The Substantia Nigra (SN) is one region 
neighbouring the VTA which could be affected by the spread of intracranial 
administration of the drug. There is however substantial evidence which has 
demonstrated functional differences between the VTA and SN. For example, 
Deutch et al., (1985) demonstrated that stimuli conditioned to be feared have the 
effect upon presentation of increasing extracellular VTA DA release. This effect 
has been associated with an enhancement in VTA DA neural activity. Also in 
support are findings that lesioning the VTA blocks the expression of FPS, 
whereas 6-OHDA lesions made directly to the SN, which has been shown to 
reduce DA upon application, does not block the FPS response (Borowski & 
Kokkinidis, 1996; Hitchcock & Davis 1991). Next, it has been demonstrated that 
the stimulation of the SN electrically, does not increase acoustic startle 
amplitudes in the rat. In contrast to this electrical stimulation of the VTA does 
produce an increase in the rat acoustic startle response (Borowski & Kokkinidis, 
1996).  
 
 As previous research into this area has noted (Giftkins, Greba, & 
Kokkinidis, 2002), the primary brainstem startle pathway which runs to the 
amygdala transverses both the VTA and SN. The placement of the guide 
cannulas inserted intracranially into the VTA is located dorsal to the startle 
pathway, however the possibility remains that this circuitry may have become 
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damaged. Evidence against this occurring is provided however by the results 
obtained from the control group. The control group subjects were administered 
saline, and then tested in circumstances paralleling the groups that received the 
antagonist drugs. Drug and saline infusion was performed, the results 
demonstrate that shock reactivity levels were not impaired by the drug 
administration.  
  
 The administration if bicuculline, a GABAa receptor antagonist into the 
VTA increases species typical fear responses such as defensive freezing and the 
startle response, whereas bicuculline infusion to the SN produces behaviours not 
associated with emotionality, such as an increase in grooming, head turning, and 
circling behaviours (Greba et al., 2000; Stevens, Wilson, & Foote, 1974). Finally, 
it has been shown that lesioning of the VTA or the amygdala produces a 
decrease in fear responding; whereas lesioning to the SN does not reduce fear 
responses (Galey, Simon, & LeMoal, 1977).       
  
  
 
 
 
 
 
   45
   
5.2 CNQX 
 
 CNQX is an AMPA receptor antagonist that reportedly binds with AMPA 
receptors on VTA DA neurons (Harris, Winner, Byrne, & Aston Jones, 2004). The 
findings from the groups administered 5ug, 2.5ug, and 1.0ug of the AMPA 
receptor antagonist CNQX provide support for glutamate playing a role in the 
neurochemistry contributing to the development of CS-UCS associations 
(Figures 6 & 7). This finding lends further weight to the assertion that 
glutamatergic AMPA receptors are involved in fear conditioning. As was the case 
with the subjects administered AP5, those rats administered decreasing doses of 
CNQX demonstrated normal levels of sensory-motor processing post-drug 
infusion (Figure 8). Similarly, the levels of reactivity to footshock was also 
unimpaired as a result of AMPA receptor antagonist administration, this indicates 
that the animal’s perception of the footshock was not impaired. 
 
5.3 Mesocorticolimbic Involvement in Fear Conditioning 
  
 Pharmacological and lesion experiments have demonstrated that VTA DA 
neural activity is a necessary component of the pathway that governs classically 
conditioned fear (Borowski & Kokkinidis, 1996; Munro & Kokkinidis, 1997; Greba 
et al., 2000). Repeating the AP5 results, CNQX blocked the ability of a CS – US 
associations to become formed and as a consequence elicit the fear potentiated 
startle response upon testing. The results of the CNQX study suggest that AMPA 
receptors may take part in the complex neural processes necessary for fear 
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learning and the FPS response. The data from the CNQX experiments also 
suggests that the VTA may be an area where NMDA and AMPA mediated 
processes associated with LTP occur. As has been discussed above, the 
activation of NMDA and AMPA receptors are involved in the cellular processes 
governing the synaptic alterations associated with LTP. In this study intra-VTA 
infusion of the AMPA receptor antagonist CNQX had similar effects on learning 
processes required in fear conditioning as that produced by research into 
amygdaloid LTP (Sigurdsson, Doyère, Cain, & LeDoux, 2006).  
 
 As was the case in past experiments examining the anatgaonism of VTA 
NMDA receptors within the basolateral nucleus of the amygdala produced a 
disruption in fear learning (Walker et al., 2002). Given their anatomical and 
neurochemical connectivity, the results from this study and research into 
glutamate transmission within the amygdala (Walker et al., 2002) suggest that 
both areas may participate in the development of fear learning.  
 
5.4 Long Term Potentiation  
  
 It has been shown that glutamatergic receptors on VTA DA neurons are 
involved in drug induced LTP (Harris et al., 2004). This indicates that the 
processing of information governing conditioned responding may be mediated by 
glutamatergic inputs into the VTA. Evidence supporting this assertion comes 
from research investigating LTP-like synaptic enhancements in other brain areas. 
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Data has shown that the stimulation of hippocampal and amygdala afferents 
produces synaptic changes significantly associated with LTP (Chapman, Kairiss, 
Keenan, & Brown, 1990; Walker & Davis, 2002). Davis and colleagues have 
suggested that the synaptic mechanism involved the production of LTP may also 
be involved and analogous to the processes involved in fear conditioning (Walker 
et al., 2002).  
 
 It has been suggested that the mechanisms underlying LTP are similar to 
those processes involved in fear production and the rewarding properties of drug 
related effects (Rogan, Staubli, & LeDoux, 1997). Further evidence that supports 
glutamate’s role in mediating behavioural conditioning comes from research 
involving a drug induced form of LTP. Research has demonstrated that 
Glutamate associated neural plasticity within the VTA is involved in learning to 
associate specific environmental stimuli that have been temporally linked to 
exposure from cocaine and morphine exposure (Harris & Aston Jones, 2003; 
Harris, Winner, Byrne, & Aston Jones, 2004). This research demonstrated that 
environmental stimuli previously associated with the reinforcing effects of drugs, 
namely cocaine and morphine, may develop their conditioned association 
through a glutamatergic process that governs neural plasticity (Harris et al., 
2003). The development of conditioned associations between environmental 
stimuli and drugs of abuse has been shown to involve glutamate based neural 
plasticity (Winder, Egli, Schramm, Matthews, 2002), it may also be possible that 
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this same process underlies the formation of conditioned CS – US association in 
the VTA. 
 
 DA modulation and transmission within the mesocorticolimbic systems has 
been shown to be involved in learning and executing conditioned defensive 
behaviours (Beninger & Phillips, 1980; Harris et al., 2004). Opiate interaction 
within VTA DA neurons has been shown to augment DA release through a 
reduction in inhibitory GABA which typically suppresses DA release (Harris et al., 
2004; Johnson & North, 1992). It has been suggested that conditioned 
environment stimuli act directly on VTA DA cells via excitatory Glutamatergic 
inputs (Harris et al., 2004; Schultz, 1998; Bespalov, Zvartau, Balster, & 
Beardsley, 2000). NMDA receptors located within the VTA and nucleus 
accumbens have been found to play a prominent role in the acquisition and 
expression of conditioned place preferences for drugs of abuse (Popik & 
Kolasiewicz, 1999). For example, the administration of the NMDA antagonists 
AP5 blocked both the acquisition and expression of a conditioned morphine 
place preference (Tzschentke & Schmidt, 1997). This research demonstrates 
further the importance of glutamatergic transmission and its role in learning and 
the expression of conditioned stimulus associations.  
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5.5 Experimental Considerations  
 
 As was the case in studies examining the hippocampus (Chapman et al., 
1990), data from this study suggests that glutamatergic NMDA and AMPA 
receptors antagonists on DA neurons within the VTA, may be involved in the 
induction of LTP. A statistical ANOVA of shock reactivity between the drug and 
saline groups (AP5 and CNQX) (Figures 4&8) demonstrated that there were no 
differences in their mean movement amplitudes. This is important because it 
indicates that any impairment in fear potentiated startle produced by infusion of 
both drugs was not due to irreversible damage to the VTA that would be 
expected to produce hypo-emotivity or decreased fear responding.  
 
 It has been reported that administration of the glutamate antagonists 
drugs AP5 and CNQX have rewarding, non-aversive effects (Harris et al., 2004; 
David, Durkin, & Cazala, 1998). This suggests that it is unlikely that glutamate 
antagonists blocked fear learning by reducing the rewarding properties inherent 
in defensively responding to a CS that predicts footshock. NMDA antagonists 
administered into the VTA have reportedly produced increases in locomotor 
activity post infusion also (Cornish, Nakamura, Kalivas, 2001). It has been 
suggested that the neural actions which enhance locomotor activity require 
inhibition of VTA GABA cells which are known to project to forebrain regions 
such as the nucleus accumbens (Van Bockstaele & Pickel, 1995) and regions of 
the pre-frontal cortex (Carr & Sesack, 2000), which are known to play a role in 
reward related learning (Wise, 2002). It has been postulated that the reinforcing 
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effects of glutamate antagonists on cells may in fact be under control of one or 
more of the areas that receives projection from the VTA (Harris et al., 2004). 
Considering the rewarding effects produced by NMDA and AMPA receptor 
antagonist drugs, the administration of these agents would enhance defensive 
startle behaviours that promote survival (Harris et al., 2004). Conversely, this 
study demonstrates that these glutamate antagonists administrated to the VTA 
impair the processes involved in fear conditioning and do not increase the 
rewarding or behavioural aspects of an acquired fear response. It is therefore 
hypothesised that the glutamate antagonists AP5 and CNQX disrupt LTP by 
interfering with the synaptic modifications within the VTA that are required in the 
acquisition of fear conditioned associations.  
  
 Previous research has demonstrated that the administration of 
methylscopolamine, a non-specific muscarinic receptor antagonist impaired the 
acquisition of conditioned fear to a CS (Greba et al., 2000). The present findings 
support the assertion made by Greba and colleagues (2000) who suggested EAA 
involvement in promoting fear motivation through VTA DA neurons. The results 
of their study indicate that glutamate receptors in the VTA are required for the 
acquisition or conditioning of fear potentiated startle responding to a previously 
neutral CS (Greba et al., 2000). Findings from this research that administration of 
the NMDA receptor antagonist AP5 blocked the acquisition of FPS is analogous 
to previous results reporting on observations from hippocampal (Maren & 
Fanselow, 1995) and amygdala studies (Melia, Miserendino, Sananes, & Davis, 
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1990). Similar results implicating NMDA receptor antagonism and its involvement 
in fear conditioning comes from research into drugs of abuse (Harris et al., 2003; 
2004). Glutamate receptor antagonism via application of the drugs AP5 and 
CNQX have also been shown to block the acquisition of a conditioned place 
preference to drugs such as morphine and cocaine (Harris & Aston Jones, 2003; 
Harris, Winner, Byrne, & Aston Jones, 2004). 
 
 The neural circuitry within the VTA where glutamate antagonists exert 
their effects on NMDA and AMPA receptors are complex and influenced by a 
variety of neural systems. The possibility exists that neurons within the VTA 
require the activation of NMDA and AMPA receptors to promote the synaptic 
changes associated with LTP (Greba et al., 2000). The results show that 
inhibition of NMDA receptor function impairs the acquisition of conditioned fear 
as measured by the FPS response. The same result also held true when the 
AMPA receptor was antagonised via administration of the antagonist CNQX. 
These results suggest that NMDA and AMPA receptors in the VTA may facilitate 
the acquisition of conditioned fear. This suggests that neural circuitry within the 
VTA undergoes synaptic transformations that have been found to be involved in 
LTP. This form of neural plasticity involves a variety of chemical interactions at 
synaptic and receptor sites involving glutamatergic NMDA and AMPA receptor 
activation.  
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 Evidence exists that supports the involvement of mesolimbic DA neurons 
arising from the VTA in fear conditioning from the PPTg and the LDTg (Greba et 
al., 2000).The present study demonstrates again that suppression of 
mesocorticolimbic DA neurons interferes with the fear potentiated startle 
response. It is known that neurons within the PPTg are one possible source for 
EAA’s in the VTA (Lavoie & Parent, 1994; Greba et al., 2000). Studies have also 
demonstrated that application of NMDA and non NMDA receptor agonists 
produce an increase in VTA DA neuronal activity (Wang & French, 1993; 
Westerink, Kwint, & De Vries, 1996). These findings raise the question of 
whether VTA DA neurons are involved in the processes involved in conditioned 
fear acquisition and memory consolidation.  
  
5.6 Possible Explanations 
  
 The hypothesis that excitatory glutamate receptor transmission within that 
VTA may contribute to the acquisition of fear conditioning in some part through 
NMDA and AMPA receptor antagonism gains some creditability from this study. 
Given its connectivity with a number of forebrain regions linked to the processing 
of emotional material, including the amygdala, hippocampus, thalamus, 
hypothalamus septum and bed nucleus of the stria terminalis (see Davis, 1992 
for review), the VTA may exert its influence over conditioned fear through 
activation of glutamate receptor systems. Using the FPS response as a measure 
of conditioned fear, within the VTA it has been possible to begin to investigate 
   53
   
the neural and neurochemical contributors to fear and the development of 
conditioned associations. It is known that the neurochemistry and neurocircuitry 
that govern fear conditioning and fear potentiated startle involve complex 
interactions between a number of different cellular and synaptic processes 
(Davis, 1993). The results of this study suggest a possible role for glutamatergic 
NMDA and AMPA receptors within the VTA. The administration of the NMDA 
receptor antagonist AP5 prior to fear conditioning blocked the acquisition of the 
FPS response. This indicates that the VTA may be a site where NMDA receptor 
mediated LTP, is involved in the acquisition of conditioned fear associations. 
Antagonism of VTA AMPA receptors prior to the fear conditioning procedure also 
demonstrated that they play a part in pavlovian fear conditioning. The 
administration of the AMPA receptor antagonist CNQX also blocked the 
acquisition of a FPS response. This indicates that AMPA receptors within the 
VTA may also be involved in acquiring a conditioned fear memory.   
 
5.7 Clinical Implications 
  
 The present results of this research have demonstrated that the 
administration of both AP5 and CNQX directly into the VTA blocked FPS. These 
findings have important implications for the current understanding of the 
neurochemical basis of disturbances in emotionality associated with abnormal 
levels of fear and anxiety in psychiatric disorders. Fearful and anxious symptoms 
common to some psychiatric disorders are often triggered by environmental 
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stimuli that signal an immediate threat which produce stimulation on circuitry 
involved in fear and anxiety. If the development of fearful conditioned responses 
could be blocked prior to new association being formed, this could provide a 
novel treatment adjunct to existing treatments. The VTA may present one site 
where future interactions could be directed.  
 
5.8 Conclusion 
  
 Data from this study indicates that gutamatergic NMDA and AMPA 
receptor activation within the VTA is required for the acquisition of learned fear 
CS – UCS association. It is postulated that the VTA may be a potential site of 
synaptic plasticity where modifications occur allowing an aversive CS to become 
associated with a UCS thereby forming a conditioned fear memory. The NMDA 
and AMPA glutamatergic receptors may also be involved in the same processes 
that occur in the previously demonstrated utilisation of glutamatergic receptor 
functioning in the amygdala (Walker et al., 2002). The present results establish 
the VTA as a site involved in fear motivational responding and indicate that the 
glutamate receptors NMDA and AMPA may contribute to the induction of LTP in 
conditioned fear acquisition. In order to further develop an understanding of VTA 
neural dynamics and those involved in FPS and LTP, future research examining 
the role of glutamate and its corresponding receptor complex is required. 
However, study will benefit from data presented by previous research into the 
VTA and the fear motivational properties of conditioned aversive stimuli.      
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